700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Research Paper Open Access
The antitumour activity of plumbagin (2-methyl 5-hydroxy, 1,4 napthoquinone) has been evaluated against Dalton's ascitic lymphoma (DAL) in Swiss albino mice. A significant enhancement of mean survival time of Plumbagin treated tumour bearing mice was found with respect to control group. Plumbagin treatment was found to enhance peritoneal cell counts. When these Plumbagin treated animals underwent I. p. inoculation with DAL cells, tumour cell growth was found to be inhibited. At 14 days after transplantation, Plumbagin treated groups were able to reverse the changes in the haemotological parameters, protein and PCV consequent to tumour inoculation.
To read the full article Peer-reviewed Article PDF
Author(s): S Kavimani R Ilango M Madheswaran B Jayakar Malaya Gupta U K Majumdar